Thursday, 29 September 2016

Amgen and Arrowhead to develop gene-therapies for heart disease

(Reuters) - Amgen Inc said on Thursday it would buy a stake in Arrowhead Pharmaceuticals Inc and team up with the company to develop gene-silencing therapies for heart disease.


Posted by at

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)